| ARCs 1-3 of human Tankyrase-1 bound to a peptide derived from IRAP | |
Heteromer
O95271; | 94-105 | |
| Assess |
| Crystal Structure of Human Insulin Regulated Aminopeptidase with Lysine in Active Site | | homo-2-mer | 159-1025 | 1×NAG; 2×ZN; 2×LYS; 15×NAG; |
| Assess |
| Crystal Structure of Human Insulin Regulated Aminopeptidase with Alanine in Active Site | | homo-2-mer | 159-1025 | 5×NAG; 2×ZN; 11×NAG; 2×UNL; |
| Assess |
| Ligand-induced conformational change of Insulin-regulated aminopeptidase: insights on catalytic mec… | | monomer | 157-1025 | 1×NAG; 3×NAG; 4×NAG; 2×NAG; 4×NAG; 1×ZN; 1×7O2; 15×BR; |
| Assess |
| Insulin-regulated aminopeptidase complexed with a macrocyclic peptidic inhibitor | | monomer | 157-1025 | 3×NAG; 1×NAG; 1×ONN; 1×ZN; 5×NAG; 1×SIN; 2×EDO; 1×PGE; 1×PG4; 1×PO4; |
| Assess |
| Insulin regulated aminopeptidase (IRAP) in complex with an allosteric aryl sulfonamide inhibitor | | monomer | 158-1025 | 1×NAG; 6×NAG; 2×NAG; 1×NAG; 3×NAG; 1×MLT; 1×ZN; 1×UKG; 1×PEG; 3×EDO; |
| Assess |
| Insulin regulated aminopeptidase (IRAP) in complex with a nanomolar alpha hydroxy beta amino acid b… | | monomer | 158-1025 | 1×NAG; 3×NAG; 1×NAG; 1×ZN; 4×NAG; 1×KFR; 3×EDO; 2×PEG; |
| Assess |
| Crystal structure of insulin regulated aminopeptidase in complex with ligand | | monomer | 159-1025 | 3×NAG; 1×NAG; 1×ZN; 7×NAG; |
| Assess |
| Insulin-regulated aminopeptidase (IRAP) in complex with an allosteric benzopyran-based inhibitor | | monomer | 160-1025 | 3×NAG; 1×NAG; 2×NAG; 1×NAG; 1×ZN; 1×UJX; 6×NAG; 1×PEG; 1×EDO; 2×GLY; |
| Assess |
| Insulin regulated aminopeptidase | | monomer | 160-1025 | 2×NAG; 1×ZN; 9×NAG; |
| Assess |